OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neuro-Oncology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas	78
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence	66
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma	60
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	57
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab	47
Comment on: “Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma”	45
Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases	45
Thalamic involvement in glioblastoma is associated with lower risk of seizures: a retrospective cohort study	44
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis	43
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population	42
Early outcomes of Gamma Knife stereotactic radiosurgery for symptomatic intracranial meningiomas in octogenarians: technique analysis and rationale	40
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline	39
Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update	38
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease	36
Immunotherapy approaches for the treatment of relapsed or progressive medulloblastoma	36
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas	35
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy	34
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study	34
Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study	33
Update of NK cell therapy in pediatric brain tumors	33
Prognostic factors among patients with brain metastases from cancer of unknown primary site	30
The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management	30
Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities	29
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor	29
Repeat stereotactic radiosurgery for treatment of brain metastases locally recurrent following initial radiosurgery	28

Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection	28
Pseudoprogression in Koos grade 4 vestibular schwannomas following stereotactic radiosurgery: temporal dynamics and radiological predictors	28
Maximal resection improves survival in MGMT methylated very elderly glioblastoma patients	27
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival	27